Home > Annual Financials > LACTOSE (INDIA)

LACTOSE (INDIA) Financial Statement Analysis
[BOM: 524202]

The Revenues of LACTOSE (INDIA) have increased by 2.20% YoY .
The Earnings Per Share (EPS) of LACTOSE (INDIA) has increased by 17.56 % YoY.
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Annual Financial Results
[BOM: 524202]

StandaloneMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹116 Cr₹114 Cr₹66 Cr₹46 Cr₹35 Cr
Expenses ₹100 Cr₹95 Cr₹54 Cr₹34 Cr₹29 Cr
Operating Profit (Excl OI) ₹17 Cr₹19 Cr₹11 Cr₹12 Cr₹6.22 Cr
Other Income ₹1.54 Cr₹1.15 Cr₹0.72 Cr₹0.58 Cr₹0.31 Cr
Interest ₹6.10 Cr₹5.25 Cr₹5.95 Cr₹5.12 Cr₹5.45 Cr
Depreciation ₹5.39 Cr₹5.22 Cr₹4.69 Cr₹4.56 Cr₹4.36 Cr
Profit Before Tax ₹6.92 Cr₹9.66 Cr₹1.46 Cr₹3.17 Cr₹-3.27 Cr
Profit After Tax ₹5.16 Cr₹6.79 Cr₹1.21 Cr₹2.45 Cr₹-2.48 Cr
Earnings Per Share (Rs)₹4.82₹4.10₹5.39₹0.96₹1.95
PAT Margin (%)3.714.445.961.845.34
ROE(%)10.9810.4015.493.036.65
ROCE(%)11.3513.0118.189.2710.21
Total Debt/Equity(x)1.061.080.810.951.06

Key Financials

Market Cap : ₹ 123.8 Cr
Revenue (TTM) : ₹ 187.7 Cr
Net Profit(TTM) : ₹ 5.2 Cr
EPS (TTM) : ₹ 3.7
P/E (TTM) : 23.7

Industry Peers & Returns1W1M1Y
LACTOSE (INDIA) -17% -13.9% -15.3%
SUN PHARMACEUTICAL INDUSTRIES -0.8% 7.3% 7.7%
DIVIS LABORATORIES -3.3% 21.8% 68.7%
TORRENT PHARMACEUTICALS -1.7% 1.9% 22.1%
CIPLA 0.7% 6.7% -9.4%
DR REDDYS LABORATORIES 0.7% 12.4% 12.4%
MANKIND PHARMA 0.2% 17.2% 15.5%
LUPIN -2.2% 0.8% -4.8%
ZYDUS LIFESCIENCES -0.9% 7.4% 27.4%


LACTOSE (INDIA) Revenues
[BOM: 524202]

Y-o-Y

2.20 %

5 Yr CAGR

35.08 %

Years Revenues % Change
Mar2026 ₹116 Cr
2.20
Mar2025 ₹114 Cr
73.10
Mar2024 ₹66 Cr
43.22
Mar2023 ₹46 Cr
31.39
Mar2022 ₹35 Cr -


LACTOSE (INDIA) Operating Profit
[BOM: 524202]

Y-o-Y

-11.12 %

5 Yr CAGR

28.32 %

Years Operating Profit % Change
Mar2026 ₹17 Cr
-11.12
Mar2025 ₹19 Cr
66.82
Mar2024 ₹11 Cr
-7.20
Mar2023 ₹12 Cr
97.04
Mar2022 ₹6.22 Cr -

Operating Margins
Y-o-Y

-13.08 %

5 Yr CAGR

-5.01 %

Years Operating Margin% % Change
Mar2026 14.49%
-13.08
Mar2025 16.67%
-3.59
Mar2024 17.29%
-35.22
Mar2023 26.69%
49.94
Mar2022 17.8% -

LACTOSE (INDIA) Profit After Tax
[BOM: 524202]

Y-o-Y

-23.95 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2026 ₹5.16 Cr
-23.95
Mar2025 ₹6.79 Cr
461.54
Mar2024 ₹1.21 Cr
-50.67
Mar2023 ₹2.45 Cr
Positive
Mar2022 ₹-2.48 Cr -

PAT Margins
Y-o-Y

-16.44 %

5 Yr CAGR

-8.70 %

Years PAT Margin(%) % Change
Mar2026 3.71 %
-16.44
Mar2025 4.44 %
-25.50
Mar2024 5.96 %
223.91
Mar2023 1.84 %
-65.54
Mar2022 5.34 % -

LACTOSE (INDIA) Earnings Per Share (EPS)
[BOM: 524202]

Y-o-Y

17.56 %

5 Yr CAGR

25.39 %

Years EPS % Change
Mar2026 ₹4.82
17.56
Mar2025 ₹4.10
-23.93
Mar2024 ₹5.39
461.46
Mar2023 ₹0.96
-50.77
Mar2022 ₹1.95 -

LACTOSE (INDIA) Return on Capital Employed (ROCE)
[BOM: 524202]

Y-o-Y

-12.76 %

5 Yr CAGR

2.68 %

Years ROCE % Change
Mar2026 11.35%
-12.76
Mar2025 13.01%
-28.44
Mar2024 18.18%
96.12
Mar2023 9.27%
-9.21
Mar2022 10.21% -

LACTOSE (INDIA) Share Price vs Sensex

Current Share Price : ₹87.2
Current MarketCap: ₹ 123.8 Cr
Updated EOD on :Nov 18,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-17%

-13.9%

-15.3%

SENSEX

0.2%

9.8%

-2.9%

LACTOSE (INDIA) related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about LACTOSE (INDIA) Financials


How the annual revenues of LACTOSE (INDIA) have changed ?

The Revenues of LACTOSE (INDIA) have increased by 2.20% YoY .

How the Earnings per Share (EPS) of LACTOSE (INDIA) have changed?

The Earnings Per Share (EPS) of LACTOSE (INDIA) has increased by 17.56 % YoY .